Clincosm LogoSign in Get a demo

relapse remitting multiple sclerosis

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Microparticle Delivered STING Agonist in Control of Experimental

Recruiting
  • Relapse Remitting Multiple Sclerosis
  • Blood Draw
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Jan 20, 2023

Relapse Remitting Multiple Sclerosis Trial in United States (Ofatumumab)

Recruiting
  • Relapse Remitting Multiple Sclerosis
  • Chandler, Arizona
  • +16 more
Jan 13, 2023

Deficient T Regulatory Cell Function in Relapsing Remitting

Recruiting
  • Relapse Remitting Multiple Sclerosis
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Jun 13, 2022

    Relapse Remitting Multiple Sclerosis Trial in Czechia, Ukraine, United States (VAY736, Placebo)

    Terminated
    Has Results
    • Relapse Remitting Multiple Sclerosis
    • Long Beach, California
    • +4 more
    Dec 9, 2020

    Relapse Remitting Multiple Sclerosis Trial (Glatiramer Acetate, N-Acetylcysteine)

    Completed
    • Relapse Remitting Multiple Sclerosis
    • Glatiramer Acetate, N-Acetylcysteine
    • (no location specified)
    May 11, 2012

    Relapse Remitting Multiple Sclerosis Trial (glatiramer acetate with minocycline, Glatiramer acetate with )

    Completed
    • Relapse Remitting Multiple Sclerosis
    • glatiramer acetate with minocycline
    • Glatiramer acetate with placebo
    • (no location specified)
    Apr 11, 2011